Definition
Synchronous telemedicine is a real-time telemedicine modality in which a patient and provider interact simultaneously via audio/video technology — replicating the interactive nature of an in-person clinical encounter through a live, two-way telecommunications connection.
Comprehensive Definition
Synchronous telemedicine, also called live video telemedicine or real-time telemedicine, is the most widely recognized form of telemedicine. It involves a real-time, two-way audio/video connection between a patient and a healthcare provider, enabling the provider to conduct a clinical assessment, discuss symptoms, review medications, and make clinical decisions in real time — without the patient and provider being in the same physical location.
The synchronous model most closely replicates the traditional in-person clinical encounter. The provider can observe the patient visually, ask and answer questions in real time, and conduct a limited physical examination using the patient's self-reported observations and any connected peripheral devices (e.g., digital stethoscopes, otoscopes, or examination cameras). For many clinical conditions — behavioral health, primary care, chronic disease management, medication management — synchronous telemedicine provides a clinically equivalent alternative to in-person care.
Medicare and most commercial insurers recognize synchronous audio/video telemedicine as the standard telemedicine modality for reimbursement purposes. Medicare covers synchronous telemedicine services under Section 1834(m) of the Social Security Act, subject to originating site and geographic requirements (many of which were waived during the COVID-19 PHE and some of which have been extended). Commercial insurers in states with telemedicine coverage parity laws are generally required to cover synchronous telemedicine on the same basis as in-person services.
Audio-only telemedicine — telephone visits without video — is a subset of synchronous telemedicine that has gained significant coverage during and after the COVID-19 PHE. CMS expanded Medicare coverage for audio-only visits during the PHE, recognizing that many patients lack access to video technology or broadband internet. Audio-only coverage rules vary by payer and state, and operators must verify current coverage rules before billing for audio-only visits.
HIPAA-compliant platforms are required for all synchronous telemedicine encounters. The platform must encrypt audio and video data in transit, implement access controls, and maintain audit logs. The covered entity must execute a Business Associate Agreement with the platform vendor. Consumer-grade video tools (standard FaceTime, standard Zoom, Google Meet without a BAA) are not HIPAA-compliant for synchronous telemedicine without appropriate configuration and a BAA.
Why It Matters
Synchronous telemedicine is the backbone of most telemedicine practices and the modality most familiar to patients and providers. Its real-time interactive nature makes it suitable for a wide range of clinical conditions — from acute care (urgent care visits, minor illness evaluation) to chronic disease management (diabetes, hypertension, heart failure) to behavioral health (therapy, psychiatry, substance use disorder treatment). For most clinical conditions where an in-person physical examination is not essential, synchronous telemedicine provides a clinically equivalent and more convenient alternative.
For healthcare operators, synchronous telemedicine is the most straightforward modality to implement from a reimbursement standpoint. Medicare and commercial payer coverage rules are most clearly defined for synchronous audio/video visits, and the billing codes (standard E/M codes with the appropriate telemedicine modifier) are well-established. Operators building telemedicine practices should start with synchronous telemedicine as their primary modality and add asynchronous or RPM components as their practice matures.
Platform selection is a critical operational decision for synchronous telemedicine practices. The platform must be HIPAA-compliant, reliable, and easy for patients to use. Poor video quality, technical difficulties, and complex login processes are among the most common reasons patients abandon telemedicine visits. Operators should evaluate platforms based on HIPAA compliance, reliability, patient experience, EHR integration, and cost — not just on feature sets.
Historical Background
Synchronous telemedicine has its roots in the early video conferencing experiments of the 1960s and 1970s. The Massachusetts General Hospital and the Logan Airport Medical Station conducted one of the earliest documented synchronous telemedicine programs in 1968, using a two-way microwave audio/video link to provide clinical consultations. The development of affordable broadband internet and consumer video technology in the 2000s made synchronous telemedicine practical at scale.
The passage of the Balanced Budget Act of 1997 established the first Medicare reimbursement for synchronous telemedicine services, though coverage was initially limited to rural areas. The ACA and subsequent legislation expanded Medicare telemedicine coverage incrementally. The COVID-19 PHE triggered the most significant expansion of synchronous telemedicine coverage in history, with CMS waiving originating site requirements and allowing synchronous telemedicine visits from patients' homes.
Federal Regulations
Medicare coverage for synchronous telemedicine is governed by Section 1834(m) of the Social Security Act and implementing regulations at 42 CFR § 410.78. Medicare covers synchronous telemedicine services for beneficiaries in rural HPSAs and non-MSAs, subject to originating site requirements — though many of these restrictions were waived during the COVID-19 PHE and some waivers have been extended through legislation.
Synchronous telemedicine services are billed using standard CPT E/M codes (99202-99215 for office visits, 90832-90838 for psychotherapy, etc.) with the telemedicine modifier GT (for Medicare) or 95 (for commercial payers). Audio-only visits may be billed using CPT codes 99441-99443 (telephone E/M services) subject to payer-specific coverage rules.
HIPAA requires synchronous telemedicine platforms to implement appropriate technical safeguards, including encryption of audio/video data in transit, access controls, and audit logs. Business Associate Agreements are required with all platform vendors. The DEA's Ryan Haight Act applies to prescribing of controlled substances via synchronous telemedicine — a prior in-person evaluation is generally required before prescribing a controlled substance via telemedicine, subject to limited exceptions.
State Considerations
State licensure requirements apply to synchronous telemedicine in the same manner as other telemedicine modalities — providers must hold an active, unrestricted license in the state where the patient is physically located at the time of the encounter. The Interstate Medical Licensure Compact (IMLC) facilitates multi-state licensure for eligible physicians.
State telemedicine practice standards govern the establishment of a valid provider-patient relationship via synchronous telemedicine. Most states permit the provider-patient relationship to be established via synchronous video visit, though some states have additional requirements (e.g., a minimum visit duration, specific documentation requirements, or restrictions on prescribing at the first visit). Audio-only visits may be subject to additional restrictions in some states.
State commercial insurance parity laws generally cover synchronous audio/video telemedicine. Audio-only coverage under commercial parity laws varies by state — some states explicitly include audio-only visits, while others limit parity to video visits. Operators must verify coverage rules for audio-only visits in each state where they operate.
Common Mistakes
- Using non-HIPAA-compliant video platforms for synchronous telemedicine encounters — consumer-grade tools without a BAA create HIPAA violations regardless of how convenient they are for patients.
- Failing to verify that treating providers hold active licenses in the states where patients are located at the time of the synchronous visit.
- Not documenting synchronous telemedicine encounters with the same rigor as in-person visits — documentation must support the E/M level billed and meet state medical board standards.
- Assuming that audio-only visits are covered by all payers — audio-only coverage rules vary significantly by payer and state, and operators must verify coverage before billing.
- Prescribing controlled substances via synchronous telemedicine without understanding the Ryan Haight Act requirements — a prior in-person evaluation is generally required.
- Selecting a telemedicine platform based solely on cost without evaluating HIPAA compliance, reliability, patient experience, and EHR integration.
Operator Insight
Platform selection is one of the most consequential decisions a telemedicine operator makes, and I see it handled poorly more often than not. The most common mistake is choosing a platform based on price or feature set without adequately evaluating HIPAA compliance and patient experience. A platform that is technically HIPAA-compliant but difficult for patients to use will result in high no-show rates and poor patient satisfaction — which ultimately hurts your practice more than a slightly higher platform cost. The audio-only question is one I get asked about constantly, particularly from operators serving older or rural patient populations. Audio-only coverage has expanded significantly since the COVID-19 PHE, but the rules are payer-specific and state-specific, and they are still evolving. My advice is to build your practice around synchronous video as the primary modality, with audio-only as a documented accommodation for patients who cannot access video — not as a default workflow. This approach minimizes compliance risk and maximizes reimbursement. For operators building behavioral health telemedicine practices, synchronous video is almost always the right modality. The therapeutic relationship in mental health care depends on visual cues and real-time interaction in a way that most other specialties do not. Asynchronous messaging and questionnaires can supplement synchronous visits, but they should not replace them for ongoing therapy or psychiatry.
— AJ Pakpour, Healthcare Practice Startup & Strategy Expert
In Practice
A direct-to-consumer urgent care telemedicine platform launches a synchronous video visit service for minor acute conditions. Patients request a visit through a mobile app, are matched with an available provider within minutes, and conduct a synchronous video visit using a HIPAA-compliant platform. The provider documents the encounter in the platform's integrated EHR, issues prescriptions as appropriate, and sends a visit summary to the patient. The platform operates in 30 states, and all providers hold active licenses in the states where they see patients. The platform bills commercial insurers using standard E/M codes with the 95 modifier. A psychiatry group launches a synchronous telemedicine practice for medication management. Patients schedule 30-minute video visits for initial evaluations and 15-minute follow-up visits for medication management. The practice uses a HIPAA-compliant video platform with a signed BAA, and all providers hold DEA registrations in the states where they prescribe controlled substances. The practice implements a controlled substance prescribing policy that requires an initial synchronous video visit before any controlled substance prescription is issued, consistent with Ryan Haight Act requirements and state medical board standards.
Frequently Asked Questions
References
Further Reading
Turn Knowledge Into Action
Apply what you just learned. Book a strategy session with AJ Pakpour — healthcare practice startup and strategy expert.
Book a Strategy Session